issued
on 06 Feb 2024
Last Applicant/ Owned by
101 Jefferson Dr 1st Floor
Menlo Park
CA
94025
Serial Number
97656065 filed on 31st Oct 2022
Registration Number
N/A
Correspondent Address
Connie Ellerbach
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Development of drugs targeting the metabolic system; Development of therapies for the prevention and treatment of metabolic disorders and diseases that affect the heart, liver, kidney and other organs; Development of pharmaceuticals for the prevention and treatment of metabolic disorders and diseases that affect the heart, liver, kidney and other organs; Pharmaceutical drug discovery and developmeRead More
Providing a website and information in the field of the prevention, diagnosis and treatment of metabolic disorders and diseases that affect the heart, liver, kidney and other organs
Development of drugs targeting the metabolic system; Development of therapies for the prevention and treatment of metabolic disorders and diseases that affect the heart, liver, kidney and other organs; Development of pharmaceuticals for the prevention and treatment of metabolic disorders and diseases that affect the heart, liver, kidney and other organs; Pharmaceutical drug discovery and development services
Human pharmaceutical preparations for the prevention and treatment of metabolic disorders and diseases that affect the heart, liver, kidney and other organs
No 97656065
No Service Mark
No 37899-00070
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 06th Feb 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 12th Dec 2023 | PUBLISHED FOR OPPOSITION |
| 12th Dec 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 22nd Nov 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 07th Nov 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 12th Oct 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 11th Oct 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 11th Oct 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 17th Aug 2023 | NON-FINAL ACTION WRITTEN |
| 17th Aug 2023 | NON-FINAL ACTION E-MAILED |
